What is Proteintech Group?
Proteintech Group is a prominent supplier of high-quality antibodies, ELISA kits, and proteins, crucial for ensuring accuracy and reproducibility in scientific research. The company's extensive product catalog supports a diverse array of applications, including Western Blot, immunohistochemistry, and flow cytometry. Proteintech Group serves researchers across various disciplines such as genomics, cancer biology, immunology, and neuroscience, offering custom services to bolster research capabilities. The company's focus on quality and breadth of offerings positions it as a key player in the scientific reagent market.
How much funding has Proteintech Group raised?
Proteintech Group has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
What's next for Proteintech Group?
The company's large-scale late-stage funding context suggests a strategic pivot towards scaling operations, expanding market reach, and potentially investing in new product development or technological advancements. This capital infusion is likely to accelerate Proteintech Group's growth, enabling it to further solidify its market leadership and cater to the evolving demands of the global research community. Future initiatives may involve enhancing manufacturing capacity, broadening its distribution network, and exploring synergistic partnerships to drive innovation in life science research.
See full Proteintech Group company page
